Article
Immune Microenvironment and Clinical Significance of PD1 Expression in Hepatocellular Carcinoma Patients
2022-02-02
Abstract excerpt
Immune checkpoint inhibitors (ICI) have revolutionized treatment for hepatocellular carcinoma (HCC), however, durable response is limited to only a subset of patients. Therefore, this study aims to identify the ICI-responsive HCC patients and to investigate the distribution of programmed death 1 (PD1) in HCC patients, as well as the relationship among PD1, pathological parameters and survival of HCC patients. A to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 36ef752f-0f5a-5324-9810-eb4ca6010123
- DOI
- 10.21203/rs.3.rs-1257996/v1
